Pernille Christina Martens

Medicine & Life Sciences

1. Infarction 100%
2. Stroke 86%
3. Petrous Bone 84%
4. Encephalocele 81%
5. Apraxias 79%
6. Glucagon-Like Peptide 1 70%
7. Peripheral Nervous System 64%
8. Eyelids 62%
9. Rare Diseases 57%
10. Income 49%
11. Gallbladder Emptying 47%
12. Necrosis 46%
13. Brain 45%
14. Radiation 44%
15. Central Nervous System 44%
16. Head 43%
17. Hormones 42%
18. Antibodies, Monoclonal, Humanized 38%
19. Glucose 37%
20. Costs and Cost Analysis 37%
21. Cerebrospinal Fluid Otorrhea 34%
22. Arteriovenous Malformations 34%
23. Bevacizumab 33%
24. Fluoroscopy 32%
25. Thrombectomy 31%
26. Glucagon-Like Peptide 2 31%
27. Bile Acids and Salts 31%
28. Ionizing Radiation 30%
29. Mortality 30%
30. Caves 29%
31. Incretins 25%
32. Vascular Endothelial Growth Factor A 25%
33. Critical Illness 24%
34. Facial Pain 24%
35. Cholecystokinin 23%
36. Gastrins 23%
37. Glucagon 20%
38. Pupillary Reflex 19%
39. SARS Virus 19%
40. Transverse Myelitis 19%
41. Hearing Loss 18%
42. Artifacts 17%
43. Magnetic Resonance Spectroscopy 16%
44. National Institutes of Health (U.S.) 15%
45. Eye 14%
46. Enteroendocrine Cells 14%
47. Cost Savings 13%
48. Alberta 13%
49. Therapeutics 13%
50. Constriction 12%